Martina Korfei

Giessen, HE 35392, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

RAAS antagonists dampen the SARS-CoV-2 infection in ex-vivo cultured human precision-cut lung slices.

RAAS antagonists dampen the SARS-CoV-2 infection in ex-vivo cultured human precision-cut lung slices.

Journal: Respiratory research

Published: May 15, 2025

Macrophage C1q contributes to pulmonary fibrosis by disturbing the metabolism of alveolar epithelial cells.

Macrophage C1q contributes to pulmonary fibrosis by disturbing the metabolism of alveolar epithelial cells.

Journal: Clinical and translational medicine

Published: March 20, 2025

Inhibition of epithelial cell YAP-TEAD/LOX signaling attenuates pulmonary fibrosis in preclinical models.

Inhibition of epithelial cell YAP-TEAD/LOX signaling attenuates pulmonary fibrosis in preclinical models.

Journal: Nature communications

Published: February 21, 2024

The Role of the Redox Enzyme p66Shc in Biological Aging of the Lung.

The Role of the Redox Enzyme p66Shc in Biological Aging of the Lung.

Journal: Aging and disease

Published: March 27, 2023

Notch1 Induces Defective Epithelial Surfactant Processing and Pulmonary Fibrosis.

Notch1 Induces Defective Epithelial Surfactant Processing and Pulmonary Fibrosis.

Journal: American journal of respiratory and critical care medicine

Published: September 01, 2022

Transcriptional Profiling of Insulin-like Growth Factor Signaling Components in Embryonic Lung Development and Idiopathic Pulmonary Fibrosis.

Transcriptional Profiling of Insulin-like Growth Factor Signaling Components in Embryonic Lung Development and Idiopathic Pulmonary Fibrosis.

Journal: Cells

Published: May 18, 2022

Identification of Paired-related Homeobox Protein 1 as a key mesenchymal transcription factor in pulmonary fibrosis.

Identification of Paired-related Homeobox Protein 1 as a key mesenchymal transcription factor in pulmonary fibrosis.

Journal: eLife

Published: April 28, 2022

Targeting Histone Deacetylases in Idiopathic Pulmonary Fibrosis: A Future Therapeutic Option.

Targeting Histone Deacetylases in Idiopathic Pulmonary Fibrosis: A Future Therapeutic Option.

Journal: Cells

Published: February 17, 2022

PACS2-TRPV1 axis is required for ER-mitochondrial tethering during ER stress and lung fibrosis.

PACS2-TRPV1 axis is required for ER-mitochondrial tethering during ER stress and lung fibrosis.

Journal: Cellular and molecular life sciences : CMLS

Published: September 07, 2021

Therapeutic induction of Bcl2-associated athanogene 3-mediated autophagy in idiopathic pulmonary fibrosis.

Therapeutic induction of Bcl2-associated athanogene 3-mediated autophagy in idiopathic pulmonary fibrosis.

Journal: Clinical and translational medicine

Published: August 31, 2021

Evaluation of Regional Pulmonary Ventilation in Spontaneously Breathing Patients with Idiopathic Pulmonary Fibrosis (IPF) Employing Electrical Impedance Tomography (EIT): A Pilot Study from the European IPF Registry (eurIPFreg).

Evaluation of Regional Pulmonary Ventilation in Spontaneously Breathing Patients with Idiopathic Pulmonary Fibrosis (IPF) Employing Electrical Impedance Tomography (EIT): A Pilot Study from the European IPF Registry (eurIPFreg).

Journal: Journal of clinical medicine

Published: November 14, 2020

Clinical and Functional Characteristics of Patients with Unclassifiable Interstitial Lung Disease (uILD): Long-Term Follow-Up Data from European IPF Registry (eurIPFreg).

Clinical and Functional Characteristics of Patients with Unclassifiable Interstitial Lung Disease (uILD): Long-Term Follow-Up Data from European IPF Registry (eurIPFreg).

Journal: Journal of clinical medicine

Published: July 07, 2020

Showing 1-12 of 32

Last Updated: 09/26/2026